(Q33930928)

English

High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

D Engelbertsen

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D V Anand

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

G N Fredrikson

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D Hopkins

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

R Corder

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P K Shah

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A Lahiri

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J Nilsson

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

E Bengtsson

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

271

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

82-89

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Advanced glycation end-products: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Autoimmune response to advanced glycosylation end-products of human LDL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Innate and acquired immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

The immune response in atherosclerosis: a double-edged sword

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Autoimmunity in atherosclerosis: a protective response losing control?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Oxidation-specific epitopes are important targets of innate immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02411.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2011.02411.X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

release_ihzhqcpw6nfopbgihqnymcehue

1 reference

https://api.fatcat.wiki/v0/release/ihzhqcpw6nfopbgihqnymcehue

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33930928&oldid=1843721736"